Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
Top Cited Papers
- 1 February 2010
- journal article
- review article
- Published by Elsevier in Gastroenterology
- Vol. 138 (2), 447-462
- https://doi.org/10.1053/j.gastro.2009.11.055
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Silymarin Inhibits In Vitro T-Cell Proliferation and Cytokine Production in Hepatitis C Virus InfectionGastroenterology, 2010
- Divergent Adaptation of Hepatitis C Virus Genotypes 1 and 3 to Human Leukocyte Antigen–Restricted Immune Pressure†Hepatology, 2009
- The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus ReplicationJournal of Biological Chemistry, 2009
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 InfectionNew England Journal of Medicine, 2009
- Antiviral resistance and hepatitis B therapy #Hepatology, 2009
- Identification of HCV protease inhibitor resistance mutations by selection pressure-based methodNucleic Acids Research, 2009
- Temporal Dynamics of a Predominant Protease Inhibitor–Resistance Mutation in a Treatment-Naive, Hepatitis C Virus–Infected IndividualThe Journal of Infectious Diseases, 2009
- Expert opinion on the treatment of patients with chronic hepatitis CJournal of Viral Hepatitis, 2009
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patientsHepatology, 2008
- Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796Antimicrobial Agents and Chemotherapy, 2008